By Alex Baldwin ( February 10, 2023, 2:55 PM GMT) -- Bayer AG is pushing back at a recent bid from Indian rival Cipla Ltd. to nix a patent for Bayer's blood thinner Xarelto, claiming that Cipla merely seeks to invalidate the patent to "clear the way" for a competing product that would otherwise infringe....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.